Launched today (26 September), Cancer Core Europe brings together six cancer centres – including the Cambridge Cancer Centre at the University of Cambridge – to link cancer research through to cancer care.
Vaccines against Salmonella that use a live, but weakened, form of the bacteria are more effective than those that use only dead fragments because of the particular way in which they stimulate the immune system, according to research from the University of Cambridge published today.
A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the University of Cambridge.
Miniature scaffolds made from collagen – the ‘glue’ that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.
Research will make the study of diseases such as Parkinson’s and Alzheimer’s easier, and could lead to personalised therapies for a variety of neurodegenerative disorders.
Scientists at the University of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing.
A new app which turns any smartphone into a portable medical diagnostic device could help in the fight against diseases including HIV, tuberculosis and malaria in the developing world.
New research shows that, contrary to what was previously assumed, suppressing unwanted memories reduces their influence on behaviour, and sheds light on how this process happens in the brain.
A University of Cambridge cancer research laboratory which uses imaging technologies to measure key biologic changes within growing tumours has announced a three-year oncology research collaboration with Medimmune.
Two teams of University of Cambridge students have won a prestigious international competition to commercialise innovative breast cancer research.
© 2025 University of Cambridge